No Data
Jiangsu Hualan New Pharmaceutical MaterialLtd's (SZSE:301093) Shareholders Have More To Worry About Than Only Soft Earnings
Hualan Co., Ltd.: Report for the first quarter of 2025
Can Mixed Fundamentals Have A Negative Impact on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Current Share Price Momentum?
Hualan Co., Ltd. (301093.SZ): Signed a global strategy cooperation agreement with Gan & Lee Pharmaceuticals.
On April 22, Gelonghui reported that Hualan Co., Ltd. (301093.SZ) announced that the company and Gan & Lee Pharmaceuticals have reached a consensus on their cooperative relationship regarding bromobutyl rubbers pistons for pen-type syringes and aluminum caps (including bromobutyl rubber gaskets) for pen-type syringes (referred to as "pen-type packaging materials"). Both parties are willing to establish a long-term and friendly global strategy partnership. They have signed a relevant agreement, which will take effect after being signed and sealed by the legal representatives or authorized representatives of both parties, with an initial term of 3 years.
Hualan Co., Ltd.: 2024 Annual Report Summary
Hualan Co., Ltd.: 2024 Annual Report
The Returns On Capital At Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093) Don't Inspire Confidence
